Also known as: coordna bio
Converting biology into digital molecular maps
Company is active
Event Year: 2024
Company is active
Event Year: 2024
Biocartesian is revolutionizing drug discovery by enhancing our understanding of disease at the molecular level. Identifying effective treatments hinges on pinpointing the location and nature of abnormal molecules within diseased tissue. Existing technologies, however, capture less than 1% of these crucial molecules. Biocartesian addresses this limitation by integrating advanced microscopy techniques with innovative chemical processes, enabling researchers to visualize up to 50 times more molecules. This enhanced visibility provides unprecedented insights into the complexities of disease biology, paving the way for the development of novel and targeted therapeutic interventions.
Biocartesian is revolutionizing drug discovery by enhancing our understanding of disease at the molecular level. Identifying effective treatments hinges on pinpointing the location and nature of abnormal molecules within diseased tissue. Existing technologies, however, capture less than 1% of these crucial molecules. Biocartesian addresses this limitation by integrating advanced microscopy techniques with innovative chemical processes, enabling researchers to visualize up to 50 times more molecules. This enhanced visibility provides unprecedented insights into the complexities of disease biology, paving the way for the development of novel and targeted therapeutic interventions.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2024
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2024
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 2
Hiring: No
Team size: 2
Hiring: No